Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04216329 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04216329
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2023-09-29
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.